Vanda Pharmaceuticals Earnings: Here’s Why Shares are Up Now

Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) had a loss and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are up 0.82%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Vanda Pharmaceuticals, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share increased to $-0.15 in the quarter versus EPS of $-0.28 in the year-earlier quarter.

Revenue: Decreased 0.49% to $8.1 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Vanda Pharmaceuticals, Inc. reported adjusted EPS loss of $0.15 per share. By that measure, the company beat the mean analyst estimate of $-0.25. It missed the average revenue estimate of $8.42 million.

Quoting Management: There was no comment from management.

Key Stats (on next page)…